九洲药业1月9日获融资买入5484.35万元，融资余额4.88亿元

Group 1 - The core viewpoint of the news is that Jiuzhou Pharmaceutical has shown significant trading activity and financial performance, with a notable increase in stock price and trading volume on January 9, 2025 [1] - On January 9, Jiuzhou Pharmaceutical's stock price increased by 3.18%, with a trading volume of 465 million yuan. The net financing purchase was 5.38 million yuan, indicating strong investor interest [1] - As of January 9, the total margin balance for Jiuzhou Pharmaceutical was 489 million yuan, with financing accounting for 2.82% of the circulating market value, which is above the 60th percentile of the past year [1] Group 2 - As of September 30, 2025, Jiuzhou Pharmaceutical reported a total revenue of 4.16 billion yuan, representing a year-on-year growth of 4.92%, and a net profit attributable to shareholders of 748 million yuan, up 18.51% year-on-year [2] - The company has distributed a total of 2.18 billion yuan in dividends since its A-share listing, with 1.25 billion yuan distributed in the last three years [3] - The number of shareholders increased to 59,200, with an average of 15,035 circulating shares per person, a decrease of 9.27% from the previous period [2]